MAPK3 and ovarian carcinoma: In conclusion, the present study elucidates that cardamonin controls cell proliferation through inducing oxidative stress and reveals an underlying cross talk between mTORC1 and ERK1/2 pathways via Raptor, providing a promising target for novel drug development and ovarian cancer therapy.